Rania Hussien1, Sarah Ahmed1, Hanem Awad2, Maged El-Setouhy3,4, Mohamed El-Shinawi5, Jon Mark Hirshon6. 1. Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, Ain Shams University, Cairo, Egypt. 2. Regulatory Toxicology Lab, Centre of Excellence, National Research Centre, Cairo, Egypt. 3. Department of Family and Community Medicine, Faculty of Medicine, Jazan University, Jazan, Saudi Arabia. 4. Department of Community, Environmental and Occupational Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt. 5. Department of Surgery, Faculty of Medicine, Ain Shams University, Cairo, Egypt. 6. Department of Emergency Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Abstract
BACKGROUND: 'Voodoo' is a new substance of abuse that recently spread among youth in Egypt. It has numerous potentially dangerous effects on humans. However, to date the composition of the main constituents of this compound is unknown. PURPOSE: We sought to identify the active components of this unknown substance"voodoo". METHODS: Three samples were collected and analysed by high-performance liquid chromatography with photodiode array detector (HPLC-PAD), gas chromatography/mass spectrometry (GC/MS), and ultra-performance liquid chromatography/mass spectrometry (UPLC-MS/MS) using targeted multiple reaction monitoring (MRM). RESULTS: HPLC-PAD analysis showed that samples 1 and 2 had some common major peaks, the same retention time, and similar spectra, whereas sample 3 showed different peaks. GC/MS analysis revealed the presence of various putatively identified bioactive compounds, including quinazolines, morphinan alkaloid, cannabinoids, penitrem A, and the well-known synthetic cannabinoid FUB-AMB (methyl(2S)-2-{[1-[(4-fluorophenyl)methyl]indazole-3-carbonyl]amino}-3 methylbutanoate). UPLC-MS/MS analysis revealed the presence of common compounds such as tetrahydrocannabinol (THC), amphetamine, 3,4-methylenedioxyamphetamine, tramadol, and oxazepam. CONCLUSION: We concluded that Voodoo is a mixture of substances of abuse at varying concentrations.
BACKGROUND: 'Voodoo' is a new substance of abuse that recently spread among youth in Egypt. It has numerous potentially dangerous effects on humans. However, to date the composition of the main constituents of this compound is unknown. PURPOSE: We sought to identify the active components of this unknown substance"voodoo". METHODS: Three samples were collected and analysed by high-performance liquid chromatography with photodiode array detector (HPLC-PAD), gas chromatography/mass spectrometry (GC/MS), and ultra-performance liquid chromatography/mass spectrometry (UPLC-MS/MS) using targeted multiple reaction monitoring (MRM). RESULTS: HPLC-PAD analysis showed that samples 1 and 2 had some common major peaks, the same retention time, and similar spectra, whereas sample 3 showed different peaks. GC/MS analysis revealed the presence of various putatively identified bioactive compounds, including quinazolines, morphinan alkaloid, cannabinoids, penitrem A, and the well-known synthetic cannabinoid FUB-AMB (methyl(2S)-2-{[1-[(4-fluorophenyl)methyl]indazole-3-carbonyl]amino}-3 methylbutanoate). UPLC-MS/MS analysis revealed the presence of common compounds such as tetrahydrocannabinol (THC), amphetamine, 3,4-methylenedioxyamphetamine, tramadol, and oxazepam. CONCLUSION: We concluded that Voodoo is a mixture of substances of abuse at varying concentrations.
Entities:
Keywords:
Egypt; Substance abuse; Voodoo; chemical analysis; identification
Authors: Han Na Seo; Ja Youn Choi; Yun Jeong Choe; Yoonjee Kim; Hyewhon Rhim; So Ha Lee; Jungahn Kim; Dong Jun Joo; Jae Yeol Lee Journal: Bioorg Med Chem Lett Date: 2007-09-01 Impact factor: 2.823
Authors: Wendy L Imlach; Sarah C Finch; James Dunlop; Andrea L Meredith; Richard W Aldrich; Julie E Dalziel Journal: J Pharmacol Exp Ther Date: 2008-09-18 Impact factor: 4.030
Authors: Angel S Moldes-Anaya; Frode Fonnum; Gunnar S Eriksen; Thomas Rundberget; S Ivar Walaas; Mattis B Wigestrand Journal: Neurochem Int Date: 2011-09-06 Impact factor: 3.921
Authors: Giovanni Martinotti; Matteo Lupi; Tiziano Acciavatti; Eduardo Cinosi; Rita Santacroce; Maria Salvina Signorelli; Laura Bandini; Giulia Lisi; Diego Quattrone; Paola Ciambrone; Andrea Aguglia; Federica Pinna; Salvatore Calò; Luigi Janiri; Massimo di Giannantonio Journal: Biomed Res Int Date: 2014-07-15 Impact factor: 3.411
Authors: Asha S Ripanda; Mwemezi J Rwiza; Elias Charles Nyanza; Revocatus L Machunda; Said Hamadi Vuai Journal: J Environ Public Health Date: 2022-06-08
Authors: Ahmed Hashim; Nouran A Mohammed; AlFadl Othman; Mohab A K Gab-Allah; Ahmed H M Al-Kahodary; Eslam R Gaber; Ahmed M Hassan; Mahmoud Aranda; Rania Hussien; Amany Mokhtar; Md Saiful Islam; Ka Yiu Lee; Muhammad Sohaib Asghar; Muhammad Junaid Tahir; Zohaib Yousaf Journal: Heliyon Date: 2022-08-12
Authors: Ahmed E Elsukary; Ahmed M N Z Helaly; Amal A El Bakary; Maha E Moustafa; Mohammad A El-Kattan Journal: Neurotox Res Date: 2022-08-17 Impact factor: 3.978